ArticleJournal of global infectious diseases
Global Contributors to Antibiotic Resistance.
Article in Journal of global infectious diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 304 papers, 8 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
304 citing papers in PubMed, 8 syntheses or guidelines pooled it.
- Global status of antimicrobial resistance in clinical Enterococcus faecalis isolates: systematic review and meta-analysis.Annals of clinical microbiology and antimicrobials · 2024Pooled it
- Mapping the oral resistome: a systematic review.Journal of medical microbiology · 2024Pooled it
- Substandard and falsified antimicrobials in selected east African countries: A systematic review.PloS one · 2024Pooled it
- Prevalence of colistin resistance in clinical isolates ofFrontiers in microbiology · 2024Pooled it
- Comparative meta-analysis of antimicrobial resistance from different food sources along with one health approach in the Egypt and UK.BMC microbiology · 2023Pooled it
- Increasing prevalence of malaria and acute dengue virus coinfection in Africa: a meta-analysis and meta-regression of cross-sectional studies.Malaria journal · 2023Pooled it
- Current State of Knowledge Regarding WHO High Priority Pathogens-Resistance Mechanisms and Proposed Solutions through Candidates Such as Essential Oils: A Systematic Review.International journal of molecular sciences · 2023Pooled it
- A systematic literature review and meta-analysis of community pharmacist-led interventions to optimise the use of antibiotics.British journal of clinical pharmacology · 2022Pooled it
- No role of antibiotics in patients with chest trauma requiring inter-costal drain: a pilot randomized controlled trial.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2023Trial
- Article
- Article
- Coumarins Disrupt Cell-Cell Communication and Virulence in Priority Pathogens: Targeting the PQS Signalling System in Pseudomonas aeruginosa.Microbial biotechnology · 2026Article
- Spatial distribution and determinants of antimicrobial resistance in livestock across pathogen types, animal species and antimicrobial classes.BMC veterinary research · 2026Article
- Knowledge, Attitudes, and Practices of Cattle Farmers Regarding Antibiotic Use and Antimicrobial Resistance in Selected Districts of Zambia.Antibiotics (Basel, Switzerland) · 2026Article
- Antimicrobial resistance in India's dairy value chain: An investigation of risk factors in Haryana and Assam, India.One health (Amsterdam, Netherlands) · 2026Article
- Aquatic bacterial and antimicrobial resistance profile at different fish farms in Accra.Journal of water and health · 2026Article
- Linking access to stewardship: a pathway for introducing reserve antibiotics in India.JAC-antimicrobial resistance · 2026Review
- Development Process of a Clinical Decision Support System for Empiric Antibiotic Therapies in Patients With Sepsis: Case Study.JMIR medical informatics · 2026Article
- Primary caregivers' practices and perceptions on antibiotic use and resistance: a one health qualitative study in rural South India.BMJ open · 2026Article
- Infectious Diseases and Antimicrobial Resistance in the Gaza Strip: Epidemiological Drivers, Health System Disruptions, and Global Implications: A Narrative Review.Health science reports · 2026Article
244 more citing papers are in PubMed but not listed here.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionAntibiotic-resistant infections have become increasingly prevalent nowadays. As a result, it is essential to examine the key socioeconomic and political factors which contribute to the rise in the prevalence of antibiotic resistance in developing and developed nations. This study aims to identify the various contributors to the development of antibiotic resistance in each type of nation.
methodsPUBMED was used to identify primary research, systematic reviews, and narrative reviews published before Jan 2017. Search terms included antibiotic resistance, antimicrobial resistance, superbugs, multidrug-resistant organisms, developing countries, developed countries. Publications from different countries were included to ensure generalizability. Publications were excluded if they didn't mention factors causing resistance, focused on the molecular basis of resistance, or if they were case reports. Publicly available reports from national and international health agencies were used.
resultsIn developing countries, key contributors identified included: (1) Lack of surveillance of resistance development, (2) poor quality of available antibiotics, (3) clinical misuse, and (4) ease of availability of antibiotics. In developed countries, poor hospital-level regulation and excessive antibiotic use in food-producing animals play a major role in leading to antibiotic resistance. Finally, research on novel antibiotics is slow ing down due to the lack of economic incentives for antibiotic research.
conclusionOverall, multiple factors, which are distinct for developing and developed countries, contribute to the increase in the prevalence of antibiotic resistance globally. The results highlight the need to improve the regulatory framework for antibiotic use and research globally.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.